Investment Summary

Eight Roads Invests In Turnstone Biologics

On November 2, 2016, private equity firm Eight Roads invested in life science company Turnstone Biologics

Investment Highlights
  • This is Eight Roads’ 39th transaction in the Life Science sector.
  • This is Eight Roads’ 1st transaction in Canada.
  • This is Eight Roads’ 1st transaction in Ontario.

Investment Summary
Date 2016-11-02
Target Turnstone Biologics
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target

Turnstone Biologics

Ottawa, Ontario, Canada
Turnstone Biologics is a privately-held clinical-stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading and complementary platforms that drive innate and adaptive tumor immunity, to provide benefit to the millions of cancer patients underserved by current treatment options. Turnstone Biologics was founded in 2015 and is based in Ottawa, Ontario.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Eight Roads

Investor

Category Private Equity Firm
Founded 1969
Size Small
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 133 of 298
Sector (Life Science) 39 of 74
Type (Venture) 113 of 269
State (Ontario) 1 of 2
Country (Canada) 1 of 3
Year (2016) 19 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-18 Eywa Pharma

Singapore, Singapore

Eywa Pharma is a global generic pharmaceutical company, has been founded by a group of seasoned professionals with extensive experience in the global pharmaceutical industry with proven ability in creating successful, profitable entities across multiple business verticals. Eywa Pharma was founded in 2015 and is based in Singapore.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-11 Northern Arc

Chennai, India

Northern Arc is a non-banking finance corporation providing the crucial link between debt capital markets and high quality Originators who reach out to the emerging consumers and business owners. Using its deep experience, unrivalled data processing skills, proven and proprietary risk management processes. Northern Arc was founded in 2008 and is based in Chennai, India.

Buy -
Mergr

Product

Company

Legal